BAFMX
Price
$17.50
Change
+$0.02 (+0.11%)
Updated
Nov 18 closing price
Net Assets
46.46M
FSMAX
Price
$96.78
Change
+$0.13 (+0.13%)
Updated
Nov 18 closing price
Net Assets
41.46B
Interact to see
Advertisement

BAFMX vs FSMAX

Header iconBAFMX vs FSMAX Comparison
Open Charts BAFMX vs FSMAXBanner chart's image
Brown Advisory Mid-Cap Growth Instl
Price$17.50
Change+$0.02 (+0.11%)
VolumeN/A
Net Assets46.46M
Fidelity Extended Market Index
Price$96.78
Change+$0.13 (+0.13%)
VolumeN/A
Net Assets41.46B
BAFMX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
BAFMX vs. FSMAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAFMX is a Hold and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.5B vs. BAFMX (46.5M). FSMAX pays higher dividends than BAFMX: FSMAX (0.43) vs BAFMX (0.00). BAFMX was incepted earlier than FSMAX: BAFMX (7 years) vs FSMAX (14 years). BAFMX (0.85) is less costly to investors than FSMAX (0.04). BAFMX is a more actively managed with annual turnover of: 73.00 vs. FSMAX (15.00). FSMAX has a lower initial minimum investment than BAFMX: FSMAX (0) vs BAFMX (1000000). FSMAX annual gain was more profitable for investors over the last year : 4.46 vs. BAFMX (3.25). FSMAX return over 5 years is better than : 33.47 vs. BAFMX (3.43).
BAFMXFSMAXBAFMX / FSMAX
Total Expense Ratio0.830.042,371%
Annual Report Gross Expense Ratio0.850.042,429%
Fund Existence7 years14 years-
Gain YTD3.4936.34955%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets46.5M41.5B0%
Annual Yield % from dividends0.000.43-
Returns for 1 year3.254.4673%
Returns for 3 years34.8849.7170%
Returns for 5 years3.4333.4710%
Returns for 10 yearsN/A93.83-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INTO0.20N/A
N/A
Initio, Inc.
BOSSY8.53N/A
N/A
Hugo Boss AG
CYDY0.29-0.03
-8.44%
CytoDyn Inc.
UPMKF25.06-4.24
-14.47%
UPM-Kymmene Corp.
OTLC0.08-0.01
-15.70%
Oncotelic Therapeutics, Inc.